COVID-19 Antiviral and Treatment Candidates: Current Status
- Author:
Erica ESPAÑO
1
;
Dajung KIM
;
Jiyeon KIM
;
Song-Kyu PARK
;
Jeong-Ki KIM
Author Information
- Publication Type:Review Article
- From:Immune Network 2021;21(1):e7-
- CountryRepublic of Korea
- Language:English
- Abstract: The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 has severely impacted global health and economy. There is currently no effective approved treatment for COVID-19; although vaccines have been granted emergency use authorization in several countries, they are currently only administered to high-risk individuals, thereby leaving a gap in virus control measures. The scientific and clinical communities and drug manufacturers have collaborated to speed up the discovery of potential therapies for COVID-19 by taking advantage of currently approved drugs as well as investigatory agents in clinical trials. In this review, we stratified some of these candidates based on their potential targets in the progression of COVID-19 and discuss some of the results of ongoing clinical evaluations
